Taysha Gene Therapies's total assets for Q1 2025 were $138.36M, a decrease of -13.72% from the previous quarter. TSHA total liabilities were $83.30M for the fiscal quarter, a -6.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.